Student Outcomes

Where are Recent “PharmTox” Graduates?pharmtox_grad_fields

One hundred thirty (131) students have graduated with a Bachelor of Science Pharmacology-Toxicology degree from UW-Madison in the past ten years (2006-2016). The upcoming classes of 2016 and ’17 have 23 and 24 students, respectively. The degree is frequently used to develop a strong biomedical science background from which one can prepare for admission to schools of medicine, pharmacy, and other health professions programs. For 2006-15 alumni, 23 (17.6%) have earned or are pursuing MD or DO degree, 31 (23.7%) have earned or are pursuing Doctor of Pharmacy (PharmD) degrees, and 12 (9.2%) have earned or are pursuing degrees in other allied health professions, including physician’s assistant medicine (3), optometry (2), veterinary medicine (3), dentistry (1), nursing (2), and podiatry (1). Together, this accounts for 66 of the past 131 graduates (50.4%).

The degree also affords a strong research foundation forgraduate work in biomedical science fields. Among 2006-15 alumni, 30 (22.9%) have pursued further training at the graduate school level–generally in PhD programs. Pharmaceutical Sciences (8), pharmacology (10), and toxicology (3) have been the most common graduate disciplines of recent alumni; these totals include three students enrolled in prestigious medical scientist (MD/PhD) programs. Other graduate disciplines of PharmTox alumni include biomedical sciences, cellular/molecular biology, chemistry, medicinal chemistry-molecular pharmacology, neuroscience, and physiology. Several of these alumni are presently in postdoctoral research positions at various universities and research institutes nationwide (currently, 2006-15 PharmTox alumni who have earned PhDs are “postdoc-ing” at institutions including Northwestern University, Rockefeller University, University of California – Berkeley, the US Environmental Protection Agency, University of Minnesota-Twin Cities, UW-Madison, and Wake Forest University). Further,two alumni of the past decade (1.3%) have earned J.D. degrees in preparation for careers in law.

Students completing the program are well qualified to pursue entry-level scientific employment in industry (e.g. biomedical, biotechnology, consumer products, contract research organizations, or pharmaceutical).

As of December 2015, entities employing 2006-15 PharmTox alumni (representing only students who began employment immediately after graduation and exluding those who pursued advanced degrees) include the following:

  • 3M
  • Abbott Northwestern Hospital
  • AmeriCorps
  • Beghou Consulting
  • Cardno ChemRisk
  • Celltrion
  • Covance Laboratories (3)
  • Encore, a Quintiles company
  • Fabutech
  • GE Healthcare
  • Hydrite Chemical Company
  • Illinois National Guard
  • Northwestern Memorial Hospital
  • Pathway Health
  • Promega Corporation
  • SAFC
  • S.C. Johnson & Son (2)
  • SNBL USA
  • Timberline Knolls
  • University of Wisconsin School of Medicine and Public Health (3)
  • UW Health
  • Young Innovations

Medical School-PharmTox Alumni

Of the program’s 321 overall graduates, 54 (16.8%) have achieved the degree of MD or DO and 16 others are currently enrolled in such programs (those 70 equate to 21.8% of all PharmTox alumni). Medical schools attended include Wisconsin (28 PharmTox alumni), the Medical College of Wisconsin (16), as well as Minnesota (3), Michigan (2), Ross University (2), Washington (2), Boston University, Case Western Reserve, Cornell, Mayo’s Medical School, the University of Chicago, Illinois, Iowa, St. George’s, Vanderbilt, Washington University in St. Louis, and three institutions of osteopathic medicine. Fields of specialization among graduates include allergy & immunology, anesthesiology (8), cardiology (4), dermotology (1), emergency medicine (4), family practice (3), hermatology (1), internal medicine (4), neurology (1), nuclear medicine (1), obstetrics/GYN (2), orthopedics (3), otolaryngology (4), pediatrics (8), plastic/reconstructive surgery (1), psychiatry (2), pulmonary medicine (1), radiation oncology, radiology (2), general surgery (3), and urology (2). Among these aforementioned, three graduates have achieved PhDs via the physician-scientist (MD-PhD) academic track and another 3 alumni are currently in such a program.